GLP-1 (What is it?)
- GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring incretin hormone produced mainly by specialised cells in the intestine after food intake.
- It plays an important role in regulating blood glucose, appetite and digestion.
- GLP-1 is therefore associated with both metabolic regulation and appetite control.
- Medicines that mimic the action of GLP-1 are known as GLP-1 receptor agonists and are used in the management of conditions such as Type 2 diabetes and obesity.
How does GLP-1 work?
1. Blood Glucose Regulation
- GLP-1 stimulates the pancreas to release insulin when blood glucose levels rise.
- It also suppresses the release of glucagon, a hormone that raises blood glucose levels.
- Thus, GLP-1 contributes to maintaining blood glucose homeostasis.
2. Appetite Control
- GLP-1 acts on pathways involved in appetite and satiety.
- It can increase the feeling of fullness, thereby reducing food intake.
3. Slows Gastric Emptying
- GLP-1 can slow the movement of food from the stomach into the small intestine.
- This contributes to prolonged satiety and helps regulate post-meal blood glucose.
GLP-1 Receptor Agonists
- These are medicines designed to mimic the effects of naturally occurring GLP-1.
- They are used particularly in the treatment of:
- Type 2 diabetes
- Obesity and weight management, under medical supervision.
- Some newer medicines act on multiple metabolic pathways, rather than only the GLP-1 pathway.
Why are GLP-1 Drugs Important?
- They have emerged as an important development in the management of obesity and metabolic disorders.
- Their use has also generated discussion about:
- preservation of lean muscle mass during rapid weight loss;
- adequate protein and nutrient intake;
- long-term weight management;
- accessibility and affordability of obesity treatment.
Conclusion
GLP-1 represents the intersection of endocrinology, diabetes management and obesity treatment. Its growing medical use highlights a broader shift from treating obesity merely as a lifestyle issue towards recognising it as a complex metabolic condition requiring evidence-based and individualised care.
| This Concept has been Elaborately Discussed in the following Article: Protein in India: From Nutritional Need to Social-Media Fad |